NCT00002554View on ClinicalTrials.gov

Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 1993

Primary Completion Date

December 31, 1999

Study Completion Date

December 31, 1999

Conditions
Leukemia
Interventions
DRUG

busulfan

DRUG

cyclophosphamide

DRUG

methotrexate

PROCEDURE

allogeneic bone marrow transplantation

RADIATION

radioimmunotherapy

All Listed Sponsors
lead

Fred Hutchinson Cancer Center

OTHER

NCT00002554 - Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse | Biotech Hunter | Biotech Hunter